Venture Capitalist ROBUST Announces Investment in Symbiome MBC Biolabs2022-11-04T14:15:27-07:00November 4th, 2022|Startup News|
Industry Winner of the 2022 Grant Program MBC Biolabs2022-11-04T11:06:17-07:00November 4th, 2022|Startup News|
Siolta Therapeutics Announces First Newborn Dosed in Their Phase 2 ADORED Study MBC Biolabs2022-07-25T16:39:07-07:00July 25th, 2022|Startup News|
Revel Pharmaceuticals revels in new Agilent program MBC Biolabs2021-06-09T20:00:14-07:00June 9th, 2021|Startup News|
Soteria Biotherapeutics Launches with $42 Million Series A Financing Led by Roche Venture Fund and 5AM Ventures MBC Biolabs2021-05-24T13:58:30-07:00May 24th, 2021|Startup News|
Alessa Therapeutics Announces First Australian Patient Enrolled in Biolen-PC Study for Localized Drug Delivery for Prostate Cancer MBC Biolabs2021-05-24T13:42:11-07:00May 24th, 2021|Startup News|
Mitokinin, Inc., Enters into Purchase Right Agreement with AbbVie MBC Biolabs2021-03-14T12:51:41-07:00March 2nd, 2021|Startup News|
Cage Bio closes $7.2 million round of series A funding MBC Biolabs2021-02-17T10:06:22-08:00February 16th, 2021|Startup News|
BigHat Biosciences Raises $19 Million in Series A Funding MBC Biolabs2021-02-24T11:37:16-08:00February 10th, 2021|Startup News|
